PSS12 Nepafenac for the Reduction in Risk of Post-Operative Macular Oedema Associated With Cataract Surgery in Diabetic Patients- A Cost-Effectiveness Estimation for Scotland

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2059
https://www.valueinhealthjournal.com/article/S1098-3015(12)03772-2/fulltext
Title : PSS12 Nepafenac for the Reduction in Risk of Post-Operative Macular Oedema Associated With Cataract Surgery in Diabetic Patients- A Cost-Effectiveness Estimation for Scotland
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03772-2&doi=10.1016/j.jval.2012.08.2059
First page : A570
Section Title : Sensory Systems Disorders
Open access? : No
Section Order : 1544
Categories :
Tags :
Regions :
ViH Article Tags :